MyAverix Finance
US · Healthcare
Next Science Limited (NXSCF)
Drug Manufacturers - Specialty & Generic
Next Science Limited (NXSCF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for NXSCF
Next Science Limited (NXSCF) — FAQ
What is NXSCF's P/E ratio?
The price-to-earnings (P/E) ratio for Next Science Limited (NXSCF) is 18.00 (data as of 2026-03-24).
Does Next Science Limited pay a dividend?
Dividend yield is not available in the current snapshot for Next Science Limited (NXSCF). Check the MyAverix Finance app for the latest dividend data.
What sector is Next Science Limited in?
Next Science Limited (NXSCF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is NXSCF listed on?
NXSCF is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.